 |
Healthcare giant W2O has acquired Arcus Medica, the Philadelphia-based medical and scientific communications shop.
Jim Weiss, founder/CEO of W2O, called Arcus a "trailblazer" in the field, "consistently following the data to get to the right outcome for its clients."
The deal bolsters W2O's medical and scientific team to about 40 members, of which 16 are doctoral-level experts.
Arcus co-founders Mary Seideman, Jonathan Seideman and Stan Eapen will lead the rebranded W2O arcus.
"Our partnership is genuinely symbiotic, and we look forward to working together to achieve something truly great for our dynamic clients and remarkable people," said Mary Seideman.
Delancey Street Partners advised Arcus on the deal.
W2O, which is headquartered in San Francisco, is the No. 1 healthcare company in O'Dwyer's 2018 rankings with fees of $168.1M.
Jim Weiss, founder & chairman of Real Chemistry, has joined the board of ICR Inc. as it steps up its healthcare capital markets offering.
Ruder Finn has hired Kelly Yoder, who spent a dozen years at Weber Shandwick rising to North America health lead, as managing director, global head of health & life sciences.
ICR has named John Capodanno head of US healthcare corporate communications and Matthew Willey managing director in its medical technology and diagnostics practice. 
April is National Minority Health Month, spotlighting the urgency to improve health outcomes in communities of color.
In a recent conversation about the evolving media landscape, Doug Simon, CEO of D S Simon Media, spoke with Campbell O’Connor, Group Director, Media & Engagement at Real Chemistry, about how AI is influencing media relations and healthcare communications.
